Navigation Links
General Side Effect Profile I (GEN SEP I) from Novascreen-a Caliper Life Sciences Company

ProductsGeneral Side Effect Profile I (GEN SEP I) from Novascreen-a Caliper Life Sciences Company
Company Novascreen-a Caliper Life Sciences Company
Item General Side Effect Profile I (GEN SEP I)
Price 
Description Compound(s) tested through 63 ligand binding and enzyme assays spanning a broad therapeutic range. This assay panel includes many non human tissue sources and several non-selective assays. Used to determine potential side-effect liabilities of compounds.
Info Novascreen-a Caliper Life Sciences CompanyNovascreen-a Caliper Life Sciences Company
7170 Standard Drive
Hanover, Maryland
21076-1334
USA

Customer Service: 410-712-4410
Fax Number: 410-712-4412
Web Site: http://www.novascreen.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. General DNA Sequencing Services from Polymorphic DNA Technologies, Inc.
2. CNS Side Effect Profile (CNS SEP) from Novascreen-a Caliper Life Sciences Company
3. BioProfile Chemistry Analyzer from Nova Biomedical
4. Customized Profile from Novascreen-a Caliper Life Sciences Company
5. Neurological Profile from Novascreen-a Caliper Life Sciences Company
6. Gastrointestinal Profile from Novascreen-a Caliper Life Sciences Company
7. Cardiovascular/Renal Profile from Novascreen-a Caliper Life Sciences Company
8. Metabolic Profiler from Bruker Daltonics
9. Cell biology services from Novascreen-a Caliper Life Sciences Company
10. Rapidplate from Caliper Life Sciences
11. Staccato Sciclone ELISA Station from Caliper Life Sciences
(Date:11/11/2019)... ... November 11, 2019 , ... MicroGenDX, the world leader ... role in the award-winning study “Next Generation Sequencing for the Diagnosis of Periprosthetic ... laboratory processed samples using Next Generation DNA Sequencing to examine the ability of ...
(Date:11/7/2019)... (PRWEB) , ... November 07, 2019 , ... R3 Stem ... 50% off through the rest of 2019. The code to use during checkout is ... well. , R3 is the nation’s leader in regenerative therapies with over 12,000 successful ...
(Date:11/6/2019)... (PRWEB) , ... November 06, 2019 , ... ... version 2.0 today. The Genomic Search Engine now includes the ability to ... will further accelerate diagnosis of patients with genetic and rare diseases. , Patients, ...
Breaking Biology News(10 mins):
(Date:12/2/2019)... ... 2019 , ... Registration is now open for the American Society ... the Hynes Convention Center May 12-15, 2020, in Boston. The meeting is the premier ... patient advocates, and other stakeholders with the goal of advancing gene and cell therapies ...
(Date:11/19/2019)... ... November 19, 2019 , ... Supercomputing Conference – ... infrastructure solutions for Autonomous Vehicle , Medical Imaging, and Natural Language Processing ... with the Graphcore Poplar® software stack as part of its bare-metal cloud service ...
(Date:11/12/2019)... ... 12, 2019 , ... Peggy Lillis Foundation (PLF) has launched ... infection C. diff. The campaign, “See C. diff,” combines basic facts ... 30,000 people in the U.S. each year. The campaign also features a portrait ...
(Date:11/5/2019)... ... November 05, 2019 , ... Focal ... CE Mark for its Fusion Bx 2.0 prostate fusion biopsy solution. By combining ... Fusion Bx 2.0 will give urologists across Europe the ability to perform targeted ...
Breaking Biology Technology: